BioCentury
ARTICLE | Company News

Alkermes, Oklahoma negotiating value-based Medicaid purchasing agreements

August 24, 2018 9:59 PM UTC

The Oklahoma Health Care Authority (OHCA) said it has signed its first contract to negotiate value-based Medicaid purchasing agreements with Alkermes plc (NASDAQ:ALKS) for schizophrenia drug Aristada aripiprazole lauroxil.

OHCA is also close to agreements for an antibiotic and an epilepsy drug, both of which are undisclosed. The agency said it hopes to have one of the two contracts effective in September, but did not disclose details...

BCIQ Company Profiles

Alkermes plc